Gilead Sues Teva for Infringing AIDS Drug I

On Friday, Gilead Sciences, a Californian drugmaker reported filing a suit in U.S. District Court of New York, charging Teva with infringing patents related to a component of a drug to treat HIV-1 infection in adults.

This entry was posted on Monday, December 15th, 2008 at 8:22 am and is filed under Teva, drugs, pharmaceuticals, pharmaceuticals and Biotechnology. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply